In this episode, we explore the pharmaceutical landscape as Nvidia makes a strategic play, investing $50 million to catalyze Recursion's AI-driven drug discovery efforts. Join us as we discuss the collaborative potential, advancements in medical research, and the impact on the future of healthcare.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Lawfare Daily